A new rule could provide access to health care for Deferred Action for Childhood Arrivals (DACA) program recipients; North Dakota governor signs law banning most abortions in the state; legislators call on China to cooperate in investigation of COVID-19 origins.
HHS has released a notice of proposed rulemaking that could provide access to health care for Deferred Action for Childhood Arrivals (DACA) recipients. The proposed change applies to the health insurance marketplaces, the Basic Health Program, and some Medicaid and Children’s Health Insurance Programs (CHIP). If the rule is finalized, it could lead to 129,000 previously uninsured DACA recipients receiving health care coverage.
North Dakota has become the latest state to ban most abortions, only allowing abortion up to 6 weeks’ gestation in cases of rape, incest, or medical emergency, after Republican Governor Doug Burgum signed the bill into law, according to the Associated Press. The state’s only remaining abortion clinic, the Red River Women’s Clinic in Fargo, closed last year and moved across the border to Moorhead, Minnesota. The ban is expected to be challenged in court, with critics saying it will force women to seek unsafe and illegal abortions.
House legislators investigating the origins of COVID-19 have called on the Chinese government to make available Chinese scientists and military officials for testimony in Washington, according to The Hill. This comes in response to what lawmakers said were Chinese embassy efforts to interfere in the probe. The committee has requested that China make available at least 5 officials linked to the state’s health administration, the military, and the Wuhan Institute of Virology.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More